chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: Felt a little knot; Painful to move arm, couldn't move it; Hot to touch at arm; Itches sporadically; Red next to the injection site; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Felt a little knot), PAIN IN EXTREMITY (Painful to move arm, couldn't move it), VACCINATION SITE WARMTH (Hot to touch at arm), PRURITUS (Itches sporadically) and ERYTHEMA (Red next to the injection site) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE MASS (Felt a little knot), PAIN IN EXTREMITY (Painful to move arm, couldn't move it), VACCINATION SITE WARMTH (Hot to touch at arm), PRURITUS (Itches sporadically), ERYTHEMA (Red next to the injection site) and MYALGIA (Sore arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, VACCINATION SITE MASS (Felt a little knot) was resolving, PAIN IN EXTREMITY (Painful to move arm, couldn't move it) outcome was unknown and VACCINATION SITE WARMTH (Hot to touch at arm), PRURITUS (Itches sporadically), ERYTHEMA (Red next to the injection site) and MYALGIA (Sore arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Body ache; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body ache) and PYREXIA (Low grade fever) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     The patient's past medical history included Oxygen therapy since an unknown date. Concurrent medical conditions included Diabetes and COVID-19.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced PAIN (Body ache) and PYREXIA (Low grade fever). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, PAIN (Body ache) and PYREXIA (Low grade fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: High fever; Couple chills on and off; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (High fever) and CHILLS (Couple chills on and off) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 016M20A) for COVID-19 immunisation.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced PYREXIA (High fever) and CHILLS (Couple chills on and off). At the time of the report, PYREXIA (High fever) and CHILLS (Couple chills on and off) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, Pyrexia: 100.6 (High) 100.6.         Treatment information was not provided.  Concomitant medication use was not provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling hot, Induration, Pain in extremity, Periorbital swelling
Clinical narrative: 2 huge red welted marks; Arm swollen; Left eye looks puffy; didn't get my 2nd dose.; Arm was sore; Face is puffy; Arm felt itchy; Arm still has a knot in it; Arms felt hot; Felt a little tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore), PERIORBITAL SWELLING (Left eye looks puffy), SWELLING FACE (Face is puffy), URTICARIA (2 huge red welted marks) and PERIPHERAL SWELLING (Arm swollen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore), SWELLING FACE (Face is puffy), PRURITUS (Arm felt itchy), INDURATION (Arm still has a knot in it), FEELING HOT (Arms felt hot) and FATIGUE (Felt a little tired). On an unknown date, the patient experienced PERIORBITAL SWELLING (Left eye looks puffy), URTICARIA (2 huge red welted marks), PERIPHERAL SWELLING (Arm swollen) and PRODUCT DOSE OMISSION ISSUE (didn't get my 2nd dose.). The patient was treated with LORATADINE (CLARITINE) at a dose of 1 dosage form and PREDNISONE at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Arm was sore), PERIORBITAL SWELLING (Left eye looks puffy), SWELLING FACE (Face is puffy), URTICARIA (2 huge red welted marks), PERIPHERAL SWELLING (Arm swollen), PRURITUS (Arm felt itchy), INDURATION (Arm still has a knot in it), FEELING HOT (Arms felt hot) and FATIGUE (Felt a little tired) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (didn't get my 2nd dose.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.  Treatment information includes hot and cold compresses.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow-up received on 21-Jul-2021 and included New event missed dose was added and reporter details were updated. On 04-Aug-2021: Follow up received included no new information
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Product dose omission issue, Pruritus, Swelling face, Urticaria
Clinical narrative: 2 huge red welted marks; Arm swollen; Left eye looks puffy; didn't get my 2nd dose.; Arm was sore; Face is puffy; Arm felt itchy; Arm still has a knot in it; Arms felt hot; Felt a little tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore), PERIORBITAL SWELLING (Left eye looks puffy), SWELLING FACE (Face is puffy), URTICARIA (2 huge red welted marks) and PERIPHERAL SWELLING (Arm swollen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore), SWELLING FACE (Face is puffy), PRURITUS (Arm felt itchy), INDURATION (Arm still has a knot in it), FEELING HOT (Arms felt hot) and FATIGUE (Felt a little tired). On an unknown date, the patient experienced PERIORBITAL SWELLING (Left eye looks puffy), URTICARIA (2 huge red welted marks), PERIPHERAL SWELLING (Arm swollen) and PRODUCT DOSE OMISSION ISSUE (didn't get my 2nd dose.). The patient was treated with LORATADINE (CLARITINE) at a dose of 1 dosage form and PREDNISONE at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Arm was sore), PERIORBITAL SWELLING (Left eye looks puffy), SWELLING FACE (Face is puffy), URTICARIA (2 huge red welted marks), PERIPHERAL SWELLING (Arm swollen), PRURITUS (Arm felt itchy), INDURATION (Arm still has a knot in it), FEELING HOT (Arms felt hot) and FATIGUE (Felt a little tired) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (didn't get my 2nd dose.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.  Treatment information includes hot and cold compresses.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow-up received on 21-Jul-2021 and included New event missed dose was added and reporter details were updated. On 04-Aug-2021: Follow up received included no new information
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site haemorrhage, Vaccination site pain
Clinical narrative: she thinks it might have been blood or medication that run down; injection stung and kept stinging really bad; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HAEMORRHAGE (she thinks it might have been blood or medication that run down) and VACCINATION SITE PAIN (injection stung and kept stinging really bad) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (she thinks it might have been blood or medication that run down) and VACCINATION SITE PAIN (injection stung and kept stinging really bad). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 10-Mar-2021, VACCINATION SITE HAEMORRHAGE (she thinks it might have been blood or medication that run down) had resolved. At the time of the report, VACCINATION SITE PAIN (injection stung and kept stinging really bad) outcome was unknown.            concomitant medication was not provided.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: Headache; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in March 2021.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment information was not provided.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Heart rate increased, Hypoaesthesia oral, Nervousness, Pharyngeal hypoaesthesia
Clinical narrative: Very fast heartbeat; Left side of throat and tongue was numb; Left side of throat and tongue was numb; Felt like she had difficulty breathing; Got nervous; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Very fast heartbeat), HYPOAESTHESIA ORAL (Left side of throat and tongue was numb), PHARYNGEAL HYPOAESTHESIA (Left side of throat and tongue was numb), DYSPNOEA (Felt like she had difficulty breathing) and NERVOUSNESS (Got nervous) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced HEART RATE INCREASED (Very fast heartbeat), HYPOAESTHESIA ORAL (Left side of throat and tongue was numb), PHARYNGEAL HYPOAESTHESIA (Left side of throat and tongue was numb), DYSPNOEA (Felt like she had difficulty breathing) and NERVOUSNESS (Got nervous). On 10-Mar-2021, HEART RATE INCREASED (Very fast heartbeat) and DYSPNOEA (Felt like she had difficulty breathing) had resolved. At the time of the report, HYPOAESTHESIA ORAL (Left side of throat and tongue was numb) and PHARYNGEAL HYPOAESTHESIA (Left side of throat and tongue was numb) outcome was unknown and NERVOUSNESS (Got nervous) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment information was not provided.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Cough, Dyspnoea, Headache, Hypotension
Clinical narrative: shortness of breath; cough; Low blood pressure; Flu like symptoms; Headache; fever; pain; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of HYPOTENSION (Low blood pressure), INFLUENZA LIKE ILLNESS (Flu like symptoms), HEADACHE (Headache), PYREXIA (fever) and PAIN (pain) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included SALBUTAMOL (ALBUTEROL HFA) and BECLOMETASONE DIPROPIONATE (QVAR) for Asthma.    On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced HYPOTENSION (Low blood pressure), INFLUENZA LIKE ILLNESS (Flu like symptoms), HEADACHE (Headache), PYREXIA (fever), PAIN (pain) and NAUSEA (Nausea). On 07-Mar-2021, the patient experienced DYSPNOEA (shortness of breath) and COUGH (cough). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) for Headache, at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) for Headache, at an unspecified dose and frequency. On 05-Mar-2021, NAUSEA (Nausea) outcome was unknown. On 06-Mar-2021, HEADACHE (Headache) and PYREXIA (fever) outcome was unknown. At the time of the report, HYPOTENSION (Low blood pressure), INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN (pain), DYSPNOEA (shortness of breath) and COUGH (cough) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, Blood pressure measurement: 90/60 (Low) 90/60.          Treatment includes salt intake to increase   This case was linked to MOD-2021-116640 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: NNI On 07-May-2021: Updated address of reporter.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Nausea, Pain, Pyrexia
Clinical narrative: shortness of breath; cough; Low blood pressure; Flu like symptoms; Headache; fever; pain; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of HYPOTENSION (Low blood pressure), INFLUENZA LIKE ILLNESS (Flu like symptoms), HEADACHE (Headache), PYREXIA (fever) and PAIN (pain) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included SALBUTAMOL (ALBUTEROL HFA) and BECLOMETASONE DIPROPIONATE (QVAR) for Asthma.    On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced HYPOTENSION (Low blood pressure), INFLUENZA LIKE ILLNESS (Flu like symptoms), HEADACHE (Headache), PYREXIA (fever), PAIN (pain) and NAUSEA (Nausea). On 07-Mar-2021, the patient experienced DYSPNOEA (shortness of breath) and COUGH (cough). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) for Headache, at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) for Headache, at an unspecified dose and frequency. On 05-Mar-2021, NAUSEA (Nausea) outcome was unknown. On 06-Mar-2021, HEADACHE (Headache) and PYREXIA (fever) outcome was unknown. At the time of the report, HYPOTENSION (Low blood pressure), INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN (pain), DYSPNOEA (shortness of breath) and COUGH (cough) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, Blood pressure measurement: 90/60 (Low) 90/60.          Treatment includes salt intake to increase   This case was linked to MOD-2021-116640 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: NNI On 07-May-2021: Updated address of reporter.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis
Clinical narrative: having a cold; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (having a cold) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced NASOPHARYNGITIS (having a cold). At the time of the report, NASOPHARYNGITIS (having a cold) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Patient treatment includes Theraflu tea to help relieve symptoms.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pyrexia, Vaccination site induration
Clinical narrative: "lump" under the skin/marble ball under the skin"; chills; temperature was 99.8 degrees Fahrenheit.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION ("lump" under the skin/marble ball under the skin"), CHILLS (chills) and PYREXIA (temperature was 99.8 degrees Fahrenheit.) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 041L208) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE INDURATION ("lump" under the skin/marble ball under the skin"), CHILLS (chills) and PYREXIA (temperature was 99.8 degrees Fahrenheit.). At the time of the report, VACCINATION SITE INDURATION ("lump" under the skin/marble ball under the skin"), CHILLS (chills) and PYREXIA (temperature was 99.8 degrees Fahrenheit.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, Body temperature: 99.8 f (Inconclusive) 99.8 F.         No concomitant medications was reported. Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not applicable.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events,   a causal relationship cannot be excluded.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, Headache, Pyrexia
Clinical narrative: she started to feel extremely chilly; fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (she started to feel extremely chilly), PYREXIA (fever) and HEADACHE (Headache) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L2OA) for COVID-19 vaccination.     Concomitant products included LISINOPRIL and MELOXICAM for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 1. On 11-Mar-2021, the patient experienced FEELING COLD (she started to feel extremely chilly), PYREXIA (fever) and HEADACHE (Headache). At the time of the report, FEELING COLD (she started to feel extremely chilly), PYREXIA (fever) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Trearment medications were not reported.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Headache, Myalgia, Nausea
Clinical narrative: Diarrhea; Headache; Muscle pain; Joint pain; Fever; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), HEADACHE (Headache), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea), HEADACHE (Headache), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), PYREXIA (Fever) and NAUSEA (Nausea). At the time of the report, DIARRHOEA (Diarrhea), HEADACHE (Headache), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), PYREXIA (Fever) and NAUSEA (Nausea) outcome was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Diarrhea; Headache; Muscle pain; Joint pain; Fever; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), HEADACHE (Headache), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea), HEADACHE (Headache), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), PYREXIA (Fever) and NAUSEA (Nausea). At the time of the report, DIARRHOEA (Diarrhea), HEADACHE (Headache), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), PYREXIA (Fever) and NAUSEA (Nausea) outcome was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Dysphagia, Maternal exposure during pregnancy, Oropharyngeal discomfort, Pregnancy test
Clinical narrative: Pregnant; throat felt uncomfortable to swallow; throat felt uncomfortable to swallow; This spontaneous prospective pregnancy case was reported by a patient and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant), OROPHARYNGEAL DISCOMFORT (throat felt uncomfortable to swallow) and DYSPHAGIA (throat felt uncomfortable to swallow) in an adult female patient (gravida 4, para 3) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (3 drinks monthly). Concurrent medical conditions included Environmental allergy. Concomitant products included SUMATRIPTAN for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 18-Jul-2020 and the estimated date of delivery was 19-Apr-2021. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant), OROPHARYNGEAL DISCOMFORT (throat felt uncomfortable to swallow) and DYSPHAGIA (throat felt uncomfortable to swallow). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-third week of the pregnancy.  The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYTREC) at a dose of 1 dosage form. At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant), OROPHARYNGEAL DISCOMFORT (throat felt uncomfortable to swallow) and DYSPHAGIA (throat felt uncomfortable to swallow) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Sep-2020, Pregnancy test: positive (Positive) positive. On an unknown date, Blood glucose: normal (normal) normal. On an unknown date, Ultrasound scan: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitants: Prenatal vitamins was reported Estimated date of conception was 27 Jul 2020.
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound scan
Clinical narrative: Pregnant; throat felt uncomfortable to swallow; throat felt uncomfortable to swallow; This spontaneous prospective pregnancy case was reported by a patient and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant), OROPHARYNGEAL DISCOMFORT (throat felt uncomfortable to swallow) and DYSPHAGIA (throat felt uncomfortable to swallow) in an adult female patient (gravida 4, para 3) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (3 drinks monthly). Concurrent medical conditions included Environmental allergy. Concomitant products included SUMATRIPTAN for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 18-Jul-2020 and the estimated date of delivery was 19-Apr-2021. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant), OROPHARYNGEAL DISCOMFORT (throat felt uncomfortable to swallow) and DYSPHAGIA (throat felt uncomfortable to swallow). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-third week of the pregnancy.  The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYTREC) at a dose of 1 dosage form. At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant), OROPHARYNGEAL DISCOMFORT (throat felt uncomfortable to swallow) and DYSPHAGIA (throat felt uncomfortable to swallow) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Sep-2020, Pregnancy test: positive (Positive) positive. On an unknown date, Blood glucose: normal (normal) normal. On an unknown date, Ultrasound scan: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitants: Prenatal vitamins was reported Estimated date of conception was 27 Jul 2020.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Peripheral swelling, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen arm; cannot raise it), PYREXIA (fever), FATIGUE (zero energy) and HEADACHE (headache) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced PERIPHERAL SWELLING (swollen arm; cannot raise it), PYREXIA (fever), FATIGUE (zero energy) and HEADACHE (headache). At the time of the report, PERIPHERAL SWELLING (swollen arm; cannot raise it), PYREXIA (fever), FATIGUE (zero energy) and HEADACHE (headache) outcome was unknown. Concomitant medications were not reported. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: After she took the vaccine her sense of smell and taste have reappeared / As days go on her pain is getting better and she is feeling better everyday; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (After she took the vaccine her sense of smell and taste have reappeared / As days go on her pain is getting better and she is feeling better everyday) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Oral pain in 2018, Loss of smell in 2018 and Loss of taste in 2018. Concurrent medical conditions included Herpes infection (resulted in needle pricking pain in mouth, loss of taste and smell) since 2018.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (After she took the vaccine her sense of smell and taste have reappeared / As days go on her pain is getting better and she is feeling better everyday). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (After she took the vaccine her sense of smell and taste have reappeared / As days go on her pain is getting better and she is feeling better everyday) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Product administration error
Clinical narrative: Injection in the shoulder, too far up on the arm and along the needle; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT ADMINISTRATION ERROR (Injection in the shoulder, too far up on the arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Medical history was not provided).    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form(s). On 09-Mar-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (Injection in the shoulder, too far up on the arm). On 09-Mar-2021, PRODUCT ADMINISTRATION ERROR (Injection in the shoulder, too far up on the arm) had resolved. Not applicable          Reporter did not allow further contact
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Rash, Rash erythematous, Rash morbilliform, Rash pruritic
Clinical narrative: severe red rash; itchy rash; measles looking; sleeps a lot; not eating well; rash from head to toe; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (severe red rash), RASH PRURITIC (itchy rash), RASH MORBILLIFORM (measles looking), SOMNOLENCE (sleeps a lot) and DECREASED APPETITE (not eating well) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Shingles. Previously administered products included for an unreported indication: VACCINES (shingles vaccine). Concomitant products included GABAPENTIN for an unknown indication.   On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 28-Feb-2021, the patient experienced RASH ERYTHEMATOUS (severe red rash), RASH PRURITIC (itchy rash), RASH MORBILLIFORM (measles looking), SOMNOLENCE (sleeps a lot), DECREASED APPETITE (not eating well) and RASH (rash from head to toe). At the time of the report, RASH ERYTHEMATOUS (severe red rash), RASH PRURITIC (itchy rash), RASH MORBILLIFORM (measles looking), SOMNOLENCE (sleeps a lot), DECREASED APPETITE (not eating well) and RASH (rash from head to toe) outcome was unknown.            Patient took oatmeal bath in response to the events.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: severe red rash; itchy rash; measles looking; sleeps a lot; not eating well; rash from head to toe; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (severe red rash), RASH PRURITIC (itchy rash), RASH MORBILLIFORM (measles looking), SOMNOLENCE (sleeps a lot) and DECREASED APPETITE (not eating well) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Shingles. Previously administered products included for an unreported indication: VACCINES (shingles vaccine). Concomitant products included GABAPENTIN for an unknown indication.   On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 28-Feb-2021, the patient experienced RASH ERYTHEMATOUS (severe red rash), RASH PRURITIC (itchy rash), RASH MORBILLIFORM (measles looking), SOMNOLENCE (sleeps a lot), DECREASED APPETITE (not eating well) and RASH (rash from head to toe). At the time of the report, RASH ERYTHEMATOUS (severe red rash), RASH PRURITIC (itchy rash), RASH MORBILLIFORM (measles looking), SOMNOLENCE (sleeps a lot), DECREASED APPETITE (not eating well) and RASH (rash from head to toe) outcome was unknown.            Patient took oatmeal bath in response to the events.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain in extremity
Clinical narrative: Headache; Chills; Fatigue; Right arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Right arm pain), HEADACHE (Headache), CHILLS (Chills) and FATIGUE (Fatigue) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 028L20A) for COVID-19 vaccination.     No medical history was reported.    On 15-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced PAIN IN EXTREMITY (Right arm pain). On an unknown date, the patient experienced HEADACHE (Headache), CHILLS (Chills) and FATIGUE (Fatigue). At the time of the report, PAIN IN EXTREMITY (Right arm pain) had not resolved and HEADACHE (Headache), CHILLS (Chills) and FATIGUE (Fatigue) had resolved.            No Concomitant  information was  provided. No Treatment information was  provided.
Sex: U
Vaccine: COVID19
Symptoms: Type IV hypersensitivity reaction
Clinical narrative: Delayed reaction; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of TYPE IV HYPERSENSITIVITY REACTION (Delayed reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced TYPE IV HYPERSENSITIVITY REACTION (Delayed reaction). At the time of the report, TYPE IV HYPERSENSITIVITY REACTION (Delayed reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment information was not provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Syringe issue, Underdose
Clinical narrative: patient received partial 2nd dose; leaking from barrel of syringe; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (patient received partial 2nd dose) and SYRINGE ISSUE (leaking from barrel of syringe) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced UNDERDOSE (patient received partial 2nd dose) and SYRINGE ISSUE (leaking from barrel of syringe). On 25-Feb-2021, UNDERDOSE (patient received partial 2nd dose) and SYRINGE ISSUE (leaking from barrel of syringe) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Skin warm, Swelling, Vaccination site discolouration, Vaccination site erythema
Clinical narrative: Swelling; Hot to touch; Black and blue and redness right below injection site/redness had increased; Black and blue and redness right below injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (Black and blue and redness right below injection site), SWELLING (Swelling), SKIN WARM (Hot to touch) and VACCINATION SITE ERYTHEMA (Black and blue and redness right below injection site/redness had increased) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014121A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Black and blue and redness right below injection site) and VACCINATION SITE ERYTHEMA (Black and blue and redness right below injection site/redness had increased). On 10-Mar-2021, the patient experienced SWELLING (Swelling) and SKIN WARM (Hot to touch). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE DISCOLOURATION (Black and blue and redness right below injection site), SWELLING (Swelling), SKIN WARM (Hot to touch) and VACCINATION SITE ERYTHEMA (Black and blue and redness right below injection site/redness had increased) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Injection site bruising, Pain in extremity, Pyrexia
Clinical narrative: Black and blue arm; Fever; Chill; Sore arm/Hurting from shoulder to elbow; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm/Hurting from shoulder to elbow), INJECTION SITE BRUISING (Black and blue arm), PYREXIA (Fever) and CHILLS (Chill) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M2OA.) for COVID-19 vaccination.     Concomitant products included METOPROLOL for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm/Hurting from shoulder to elbow), PYREXIA (Fever) and CHILLS (Chill). On 11-Mar-2021, the patient experienced INJECTION SITE BRUISING (Black and blue arm). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 11-Mar-2021, PYREXIA (Fever) and CHILLS (Chill) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm/Hurting from shoulder to elbow) had not resolved and INJECTION SITE BRUISING (Black and blue arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication includes eczema cream.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Nausea, Pyrexia
Clinical narrative: flu like symptoms; nausea; fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), NAUSEA (nausea) and PYREXIA (fever) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027a21a) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), NAUSEA (nausea) and PYREXIA (fever). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), NAUSEA (nausea) and PYREXIA (fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm is hurting so much; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (arm is hurting so much) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and Cholesterol.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (arm is hurting so much). At the time of the report, PAIN IN EXTREMITY (arm is hurting so much) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications included unspecified high blood pressure and cholesterol medications. No treatment information was provided. Action taken with mRNA-1273 in response to events was not applicable.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: red rash around the injection site that was about the size of the palm of the hand in the shape of a; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (red rash around the injection site that was about the size of the palm of the hand in the shape of a) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced VACCINATION SITE RASH (red rash around the injection site that was about the size of the palm of the hand in the shape of a). At the time of the report, VACCINATION SITE RASH (red rash around the injection site that was about the size of the palm of the hand in the shape of a) had resolved.            concomitant medication was not provided.  Treatment information was not provided
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hypersomnia, Pyrexia, Tension headache, Vaccination site warmth
Clinical narrative: Slept all day; warmness at injection site; tension headache; fever; very tired; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (Slept all day), VACCINATION SITE WARMTH (warmness at injection site), TENSION HEADACHE (tension headache), PYREXIA (fever) and FATIGUE (very tired) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     The patient's past medical history included Diabetes since an unknown date.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 27-Feb-2021, the patient experienced HYPERSOMNIA (Slept all day), VACCINATION SITE WARMTH (warmness at injection site), TENSION HEADACHE (tension headache), PYREXIA (fever) and FATIGUE (very tired). At the time of the report, HYPERSOMNIA (Slept all day), VACCINATION SITE WARMTH (warmness at injection site), TENSION HEADACHE (tension headache), PYREXIA (fever) and FATIGUE (very tired) outcome was unknown.            No concomitant medications was reported Treatment information was not provided
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Very bad itching at the injection site; Which now is red and swollen; Which now is red and swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Very bad itching at the injection site), VACCINATION SITE ERYTHEMA (Which now is red and swollen) and VACCINATION SITE SWELLING (Which now is red and swollen) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Lung cancer.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Very bad itching at the injection site), VACCINATION SITE ERYTHEMA (Which now is red and swollen) and VACCINATION SITE SWELLING (Which now is red and swollen). At the time of the report, VACCINATION SITE PRURITUS (Very bad itching at the injection site), VACCINATION SITE ERYTHEMA (Which now is red and swollen) and VACCINATION SITE SWELLING (Which now is red and swollen) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included medicine for diabetes and lung cancer.  Treatment information was not provided.